Letter to the Editor
Targeting of C‐type lectin‐like receptor 2 or P2Y12 for the prevention of platelet activation by immunotherapeutic CpG oligodeoxynucleotides: comment

https://doi.org/10.1111/jth.13877Get rights and content
Under an Elsevier user license
open archive

Cited by (0)

See also Delierneux C, Donis N, Servais L, Wéra O, Lecut C, Vandereyken M, Musumeci L, Rahmouni S, Schneider J, Eble JA, Lancellotti P, Oury C. Targeting of C‐type lectin‐like receptor 2 or P2Y12 for the prevention of platelet activation by immunotherapeutic CpG oligodeoxynucleotides. J Thromb Haemost 2017; 15: 983–97 and Delierneux C, Donis N, Servais L, Wera O, Lancellotti P, Oury C. Targeting of C‐type lectin‐like receptor 2 or P2Y12 for the prevention of platelet activation by immunotherapeutic CpG oligodeoxynucleotides: reply. J Thromb Haemost 2017; https://doi.org/10.1111/jth.13876.

Manuscript handled by: P. H. Reitsma

Final decision: P. H. Reitsma, 16 October 2017